Trials / Recruiting
RecruitingNCT05766579
Comparison Trial Between Elastic-compressive Stockings at 21 Versus 32 mmHg
ElaStic-compressive Stockings at 21 mmHg and 32 mmHg Following Thermal Ablation of the Great Saphenous Vein.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- Sponsor
- IRCCS Policlinico S. Donato · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Endovascular thermal ablation is currently considered as the best procedure for treating varicose veins thanks to its mini-invasiveness and the lowest rate of incidence of complications. At the end of the endovascular ablation procedure, the European Society of Vascular Surgery (ESVS) guidelines recommend the use of the compression stockings to reduce postoperative pain and the incidence of edema and thrombotic complications. Despite this, the duration, type and degree of compression to be used, particularly after radiofrequency ablation procedures, remain a matter of debate. Furthermore, although the benefits of postoperative elastic compression therapy are well known, there is various evidence demonstrating how patients often experience poor comfort in wearing stockings, especially those with a higher degree of compression, which causes poor compliance with therapy. In light of all this, each center recommends the use of elastic compression stockings in the postoperative period with a degree of compression that varies, however, according to internal protocols. There is currently no work in the literature that compares the advantages and disadvantages of using elastic compression stockings with a K2 versus K1 compression degree after radiofrequency ablative surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Elastic-compressive stockings | Use of Elastic-compressive stockings at 21 mmHg and 32 mmHg. |
Timeline
- Start date
- 2019-04-02
- Primary completion
- 2026-12-30
- Completion
- 2026-12-31
- First posted
- 2023-03-13
- Last updated
- 2025-05-06
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05766579. Inclusion in this directory is not an endorsement.